Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN.
Clinical trial NCT04109482 · TERMINATED
Trial details
- NCT number
- NCT04109482
- Sponsor
- Mustang Bio
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-17
- Primary completion
- 2023-05-17
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.